Quantitative relation between hemodynamic changes during intravenous adenosine infusion and the magnitude of coronary hyperemia Implications for myocardial perfusion imaging by Mishra, Rakesh K. et al.
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Puantitative Relation Between Hemodynamic
hanges During Intravenous Adenosine Infusion
nd the Magnitude of Coronary Hyperemia
mplications for Myocardial Perfusion Imaging
akesh K. Mishra, MD, FACC,* Sharmila Dorbala, MD, FACC,* Giridhar Logsetty, MD,*
lita Hassan, MPH,† Therese Heinonen, PHD,‡ Heinrich R. Schelbert, MD, FACC,§
arcelo F. Di Carli, MD, FACC,* for the RAMPART Investigators
oston, Massachusetts; Ann Arbor, Michigan; Montreal, Canada; and Los Angeles, California
OBJECTIVES The goal of this study was to determine the relationship between changes in cardiac
hemodynamics during intravenous adenosine (ADO) infusion, and myocardial blood flow
(MBF).
BACKGROUND The relationship between changes in MBF and the peripheral hemodynamic effects during
peak adenosine infusion is unknown.
METHODS We studied 348 (age 57  11 years; 106 females) without evidence of obstructive coronary
artery disease by positron emission tomography (PET). Patients underwent [13N]ammonia
PET imaging to measure MBF and coronary vascular resistance (CVR) at rest and during a
standard 6-min ADO infusion. Changes in heart rate (HR) and mean arterial pressure
(MAP) were measured at baseline and during peak hyperemia.
RESULTS During ADO, HR increased (delta: 24  11 beats/min) and MAP decreased (delta: 2 
10 mm Hg). Overall, delta HR correlated poorly with hyperemic MBF (R  0.10, p  0.06)
and with CVR (R  0.11, p  0.04). Delta MAP also showed a weak correlation with
hyperemic MBF (R  0.04, p  0.44) and with CVR (R  0.11, p  0.04). Patients in the
lowest tertile for delta HR showed a 7% lower hyperemic MBF (1.84 0.6 ml/min/g vs. 1.98
 0.6 ml/min/g, p  0.022) and an 8% higher CVR (54  20 mm Hg/ml/min/g vs. 50 
17 mm Hg/ml/min/g, p  0.056) compared with those in the highest tertile. Patients in the
lowest tertile for delta MAP (i.e., greatest decline) showed similar hyperemic MBF, and an
8% lower CVR compared with those in the highest tertile (p  NS for both). These small
differences between tertiles remain, even after adjusting for differences in age, gender,
smoking status, and lipid profile.
CONCLUSIONS Changes in cardiac hemodynamics during intravenous ADO are generally poor predictors of
changes in MBF and CVR during peak hyperemia, and, thus, they should not be used to
assess the effectiveness of vasodilator stress in myocardial perfusion imaging. (J Am Coll
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.10.064Cardiol 2005;45:553–8) © 2005 by the American College of Cardiology Foundation
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tdenosine is a common agent for stress myocardial perfu-
ion imaging (MPI) in patients who are unable to exercise.
he sensitivity and specificity of adenosine MPI is compa-
able to that of exercise (1,2). It is a powerful vasodilator
ausing significant hyperemia in the coronary arteries.
Hemodynamic changes during adenosine infusion, par-
icularly changes in blood pressure and heart rate (HR), are
ften used in the clinical setting to assess the adequacy of
yperemia. Prior studies have shown that, generally, there is
significant increase in HR and a decrease in systolic blood
ressure during adenosine infusion (3,4). Consequently, a
ow resting blood pressure is often cited as a reason not to
nfuse adenosine due to the potential for further significant
eduction in blood pressure. In a previous study, the
iagnostic accuracy of adenosine sestamibi single-photon
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assan is employed by Pfizer Global Research and Development.P
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ccepted October 26, 2004.mission computed tomography was not affected by the
resence or absence of peripheral hemodynamic evidence of
denosine effect (5).
To date, there have not been any studies that have
irectly assessed the relationship between changes in myo-
ardial blood flow (MBF) and the peripheral hemodynamic
ffects during peak adenosine infusion. This study sought to
etermine the relationship between hemodynamic changes
uring adenosine infusion and measurements of coronary
yperemia, as quantified by [13N]ammonia and positron
mission tomography (PET).
ETHODS
atient population. We included men and women (18 to
5 years of age) without documented coronary artery disease
CAD) who completed the screening phase of the Relative
nd Absolute Myocardial Perfusion changes as measured by
ositron Emission Tomography to Assess the Effects of
CAT Inhibition: A Double-Blind, Randomized, Con-
rolled, Multicenter Trial (RAMPART) (6). The RAM-
ART trial was a phase II study designed to determine the
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Coronary Hemodynamics During Adenosine February 15, 2005:553–8ffects of Avasimibe (ACAT inhibitor) on MBF in patients
ith documented or at risk for CAD. For the current
nalysis, patients in the RAMPART study with a history of
table angina, a positive stress electrocardiogram, an abnor-
al stress myocardial perfusion or stress echocardiography
tudy, an abnormal coronary angiogram, or prior revascu-
arization were excluded (n 114). Women of childbearing
otential were excluded from the RAMPART study as were
atients with known diabetes, advanced renal dysfunction,
ctive liver disease or hepatic dysfunction, skeletal myop-
thy, uncontrolled hypertension, valvular heart disease,
ymptomatic heart failure, historical and/or diagnostic evi-
ence of left ventricular hypertrophy, unstable angina pec-
oris, or dilated cardiomyopathy (left ventricular ejection
raction 40%).
easurements of MBF. Patients underwent PET imag-
ng for assessment of MBF using whole-body PET tomo-
raphs (Siemens/CTI, Knoxville, Tennessee) at 12 U.S.
ites. All subjects refrained from caffeine-containing bever-
ges or theophylline-containing medications for 24 h before
he PET study. Patients using calcium channel blockers or
eta-blockers were instructed to withhold the medications
or 24 h before the PET study. All subjects were studied in
he fasted state.
Using [13N]ammonia, MBF was measured at rest and
uring peak hyperemia as described previously (7). A 10- to
5-min transmission scan was acquired for correction of
hoton attenuation. Beginning with the intravenous bolus
dministration of [13N]ammonia (0.286 mCi/kg), serial
mages were acquired for 19 min. A total of 30 min later,
ntravenous adenosine (0.14 mg/kg/min) was infused for
min. Three minutes into the adenosine infusion, a second
ose of [13N]ammonia was injected, and images were
ecorded in the same acquisition sequence. The HR, sys-
emic blood pressure, and 12-lead electrocardiogram were
ecorded at baseline and throughout the infusion of aden-
sine. Image acquisition protocols were standardized at each
ite, and measurements of MBF were performed at the core
aboratory (UCLA). For the purpose of this analysis,
hanges in hemodynamics (HR and blood pressure) are the
verage of values during the 2 min after the injection of
13N]ammonia corresponding to min 4 and 5 of the
denosine infusion, during which most of the myocardial
ptake of [13N]ammonia takes place and there is maximal
Abbreviations and Acronyms
CAD coronary artery disease
CFR  coronary flow reserve
CVR  coronary vascular resistance
HR  heart rate
MAP mean arterial pressure
MBF myocardial blood flow
MPI  myocardial perfusion imaging
PET  positron emission tomographyemodynamic effect of adenosine (8).
B
lata analysis. The serially acquired transaxial images were
eoriented into short-axis slices of the left ventricular
yocardium and assembled into serial polar maps, as
escribed previously (7). Regions of interest were assigned
o the territory of the left anterior descending, left circum-
ex, and right coronary arteries on the last 15-min polar
ap and copied to the serial polar maps acquired during the
nitial 2 min after intravenous [13N]ammonia injection (7).
n additional, small circular region on interest was assigned
o the center of the left ventricular blood pool. Regional
yocardial and blood pool time activity curves were then
enerated. In each coronary territory, MBF was calculated
y fitting the [13N]ammonia time-activity curves with a
alidated two-compartment tracer kinetic model (9). The
oronary flow reserve (CFR) (primary study end point) was
efined as the ratio between hyperemic and basal MBF. An
ndex of coronary vascular resistance (CVR) was calculated
y dividing the mean aortic blood pressure by MBF. The
BF, CFR, and CVR values are an average of the entire
eft ventricular myocardium.
aboratory analyses. A central laboratory (Medical Re-
earch Laboratories, Highland Heights, Kentucky) per-
ormed all clinical laboratory analyses and lipid analyses as
pecified by the standardization program of the Centers for
isease Control and Prevention and the National Heart,
ung, and Blood Institute (10).
tatistical analysis. Data are presented as mean  SD.
ifferences in baseline characteristics of patients, coronary
lood flow, CVR, and CFR between groups were compared
sing single factor analysis of variance. Significant main
ffects for group were followed with Tukey post-hoc tests to
dentify differences between groups. A multivariate analysis
f covariance design was used to investigate differences in
djusted MBF, CVR, and flow reserve between groups.
ndependent predictors of changes in CFR in response to
denosine were investigated using multiple regression anal-
sis. For all analyses an alpha of 0.05 was used to define
tatistical significance.
able 1. Baseline Characteristic of Patients
Variable
Study Subjects
(n  348)
ge (yrs) 57  11
ale gender (%) 243 (70%)
ctive smokers (%) 68 (20%)
MI (kg/m2) 29  6
otal cholesterol (mg/dl) 244  47
DL-C (mg/dl) 153  40
DL-C (mg/dl) 47  13
riglycerides (mg/dl) 219  165
asting glucose (mg/dl) 97  15
UN (mg/dl) 16  4
reatinine (mg/dl) 1.14  0.16MI  body mass index; BUN  blood urea nitrogen; HDL-C  high-density
ipoprotein-cholesterol; LDL-C  low-density lipoprotein-cholesterol.
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aseline characteristics of patients. We studied 348 per-
ons, age 22 to 80 years, considered to be at risk for CAD
s defined by a low-density lipoprotein cholesterol
130 mg/dl with two or more coronary risk factors (Table
). However, none had objective evidence of obstructive
AD as determined by the lack of regional perfusion
efects on stress myocardial perfusion PET imaging.
emodynamic changes during adenosine infusion. As
xpected, the HR and rate-pressure product increased sig-
ificantly with the infusion of adenosine (Table 2). How-
ver, the systolic and mean aortic blood pressure remained
nchanged during the infusion of adenosine.
elation between hemodynamic changes and PET mea-
ures of coronary hyperemia. Overall, changes in HR
uring adenosine correlated poorly with peak MBF (R 
.10, p  0.06) (Fig. 1), CVR (R  0.11, p  0.04), and
FR (R  0.02, p  0.77). Likewise, changes in mean
able 2. Changes in Hemodynamics
Hemodynamic Variable
Study Subjects
(n  348)
aseline
Heart rate (beats/min) 62  11
Systolic blood pressure (mm Hg) 132  21
Diastolic blood pressure (mm Hg) 72  10
Mean arterial blood pressure (mm Hg) 92  12
Rate-pressure product 8,175  2,069
denosine infusion
Heart rate (beats/min) 86  16*
Systolic blood pressure (mm Hg) 131  19*
Diastolic blood pressure (mm Hg) 69  10*
Mean arterial blood pressure (mm Hg) 90  12*
Rate-pressure product 11,279  2,749*
p  0.001 vs. baseline.igure 1. Scatter plots showing the relationships between hyperemic myocardia
hange in mean arterial pressure (right panel) during adenosine infusion.rterial blood pressure showed weak correlations with peak
BF (R  0.04, p  0.44) (Fig. 1), CVR (R  0.11, p 
.04), and CFR (R  0.27, p  0.001).
To further explore the relation between changes in HR
nd PET measures of coronary hyperemia, the study
atients were then divided into tertiles of HR change
uring adenosine infusion (lower:  HR change 19
eats/min, intermediate:  HR change 19 to 29 beats/
in, and upper:  HR change 29 beats/min) (Table 3).
ompared with the upper tertile, peak MBF in the lower
ertile was 7% lower and CVR was 8% higher (Fig. 2).
owever, there were no significant differences in CFR
etween the two groups. These small differences in peak
BF and CVR persisted after adjusting for baseline
ifferences in age, gender, smoking status, as well as total
holesterol and low-density lipoprotein cholesterol levels
data not shown).
A similar analysis was used to define the relation between
hanges in mean arterial blood (MAP) pressure (a close
stimate of coronary pressure) and PET measures of coro-
ary hyperemia. Accordingly, the study patients were di-
ided into tertiles of MAP change during adenosine infu-
ion (lower:  MAP change 5.9 mm Hg, intermediate:
MAP change 5.9 to 2.7 mm Hg, and upper:  MAP
hange 2.7 mm Hg). Compared with patients in the
pper tertile, those in the lower tertile (i.e., greatest decline
n MAP during adenosine infusion) showed similar peak
BF, CVR (Fig. 3). However, CFR was higher among
atients in the upper compared with those in the lower
ertile, reflecting the fact that the former had a lower resting
BF (Table 4). These small differences in peak MBF and
VR persisted after adjusting for baseline differences in age,
ender, smoking status, as well as total high-density li-
oprotein cholesterol levels (data not shown).l blood flow and the delta change in heart rate (left panel), and the delta
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etection of CAD with stress myocardial perfusion scin-
igraphy (MPS) relies on regional differences in radiotracer
ptake resulting from stress-induced coronary flow hetero-
eneity. During exercise, augmentation in MBF is propor-
ional to increases in myocardial oxygen demand through
hanges in HR, blood pressure, and contractility. Conse-
uently, a blunted blood flow increase downstream of an
bstructed coronary artery in the setting of an exercise-
nduced increase in oxygen demand results in myocardial
Table 3. Characteristic of Patients by Tertiles
Infusion
Variable
Lower
(n  12
Age (yrs) 60  11
Male gender (%) 100 (78
Active smokers (%) 29 (23
BMI (kg/m2) 30  7
Total cholesterol (mg/dl) 232  49
LDL-C (mg/dl) 142  39
HDL-C (mg/dl) 47  13
Triglycerides (mg/dl) 214  18
Fasting glucose (mg/dl) 98  14
Creatinine (mg/dl) 1.15  0.
Baseline heart rate (beats/min) 62  11
Baseline systolic BP (mm Hg) 131  22
Baseline diastolic BP (mm Hg) 71  10
Baseline MAP (mm Hg) 91  13
Baseline rate-pressure product 8,124  2,
Adenosine heart rate (beats/min) 75  12
Adenosine systolic BP (mm Hg) 130  20
Adenosine diastolic BP (mm Hg) 69  10
Adenosine MAP (mm Hg) 89  12
Adenosine rate-pressure product 9,717  2,
Baseline MBF (ml/min/g) 0.76  0.
Adenosine MBF (ml/min/g) 1.84  0.
Coronary flow reserve 2.61  0.
Baseline CVR (mm Hg/ml/min/g) 132  40
Adenosine CVR (mm Hg/ml/min/g) 54  20
The following p values are based on Tukey post-hoc tests
intermediate and upper tertiles; ‡p  0.019 vs. intermediate
BP  blood pressure; CVR  coronary vascular resistanc
other abbreviations as in Table 1.
igure 2. Bar charts depicting the differences in mean hyperemic myocard
nd coronary flow reserve (right panel) between the upper (UP), intermediate
nfusion. *p  0.046 vs. LOW.schemia, and a regional perfusion deficit on myocardial
erfusion scintigraphy. Thus, exercise-induced changes in
R and rate-pressure product are generally useful clinical
ndicators of the adequacy of stress and the resulting
oronary hyperemia. During vasodilator stress (e.g., adeno-
ine or dipyridamole), however, augmentation in MBF (and
onsequently flow heterogeneity) is the direct result of
ascular smooth muscle cell relaxation and endothelial
elease of nitric oxide, and largely independent of changes in
yocardial oxygen demand (11,12). Nevertheless, changes
hanges in Heart Rate During Adenosine
Intermediate
(n  111)
Upper
(n  109) p Value
56  10 55  10 0.002
77 (69) 66 (61) 0.013
23 (21) 16 (15) 0.283
29  5 29  5 0.686
247  44 254  44 0.001
158  39 162  40 0.001
47  14 47  13 0.936
215  122 230  179 0.721
98  14 95  18 0.295
1.15  0.18 1.11  0.15 0.077
62  11 62  10 0.949
131  20 132  21 0.971
71  10 72  10 0.487
91  12 92  12 0.736
8,221  2,160 8,187  1,957 0.934
87  11 99  13 0.001
130  18 131  18 0.804
68  10 71  10 0.124
89  11 91  12 0.33
11,307  2,495 13,084  2,550 0.001
0.80  0.26 0.80  0.23 0.308
2.06  0.67 1.98  0.59 0.022
2.75  1.02 2.62  0.98 0.464
124  33 123  38 0.148
48  17 50  17 0.056
0.05 vs. intermediate and upper tertiles; †p  0.001 vs.
P  mean arterial pressure; MBF  myocardial blood flow;
od flow (MBF) (left panel), coronary vascular resistance (middle panel),of C
8)
*
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February 15, 2005:553–8 Coronary Hemodynamics During Adenosinen hemodynamic parameters such as HR and blood pressure
re often used in the clinical setting to assess the adequacy
f vasodilator-induced coronary hyperemia.
The findings of this study demonstrate in a large number of
ubjects that changes in hemodynamics during adenosine-
tress are rather poor indicators of the magnitude of coronary
yperemia. We found that patients in the upper tertile of HR
hange during adenosine infusion showed only 8% higher
yperemic blood flow and 7% lower CVR, compared with
hose in the lower tertile. Further, changes in MAP during
denosine infusion were even poorer markers of the magnitude
f hyperemic blood flow. Indeed, patients in the upper tertile
igure 3. Bar charts depicting the differences in mean hyperemic myocar
oronary flow reserve (right panel) between the upper (UP), intermediate (I
nfusion. *p  0.02 vs. LOW; **p  0.001 vs. LOW.
Table 4. Characteristic of Patients by Tertiles
Adenosine Infusion
Variable
Lower
(n  11
Age (yrs) 59  1
Male gender (%) 67 (58
Active smokers (%) 20 (17
BMI (kg/m2) 29  6
Total cholesterol (mg/dl) 243  4
LDL-C (mg/dl) 154  4
HDL-C (mg/dl) 50  1
Triglycerides (mg/dl) 201  1
Fasting glucose (mg/dl) 97  1
Creatinine (mg/dl) 1.12  0
Baseline heart rate (beats/min) 64  1
Baseline systolic BP (mm Hg) 142  2
Baseline diastolic BP (mm Hg) 76  1
Baseline MAP (mm Hg) 98  1
Baseline rate-pressure product 9,104  2
Adenosine heart rate (beats/min) 87  1
Adenosine systolic BP (mm Hg) 127  1
Adenosine diastolic BP (mm Hg) 64  9
Adenosine MAP (mm Hg) 85  1
Adenosine rate-pressure product 11,114  2
Baseline MBF (ml/min/g) 0.87  0
Adenosine MBF (ml/min/g) 1.92  0
Coronary flow reserve 2.35  0
Baseline CVR (mm Hg/ml/min/g) 121  3
Adenosine CVR (mm Hg/ml/min/g) 49  1
The following p values are based on Tukey post-hoc tests
intermediate; ‡p  0.01 vs. intermediate and lower tertiles; §p 
Abbreviations as in Tables 1 and 3.i.e., lowest decline) of blood pressure change during adenosine
nfusion showed virtually identical hyperemic blood flow and
VR, compared with those in the lower tertile (i.e., highest
ecline). Importantly, these small differences in coronary cir-
ulatory dynamics persisted after adjusting for baseline differ-
nces in age, gender, smoking status, as well as total lipid levels
Tables 3 and 4). These findings suggest that changes in HR
r blood pressure during adenosine should not be used to assess
he effectiveness of vasodilator stress in patients undergoing
PI.
omparison with previous studies. In this study, adeno-
ine induced a significant increase in HR (mean: 39%,
lood flow (left panel), coronary vascular resistance (middle panel), and
and lower (LOW) tertiles of delta mean arterial pressure during adenosine
hanges in Mean Aortic BP During
Intermediate
(n  121)
Upper
(n  111) p Value
58  9 54  11* 0.003
85 (70) 91 (82) 0.001
13 (11) 35 (32) 0.001
29  6 29  5 0.967
240  42 249  49 0.312
148  37 158  41 0.115
48  14 43  11* 0.001
216  133 242  231 0.170
98  14 96  18 0.833
1.14  0.16 1.15  0.16 0.462
61  10 61  10 0.038
130  20 122  17‡ 0.001
72  9 67  10‡ 0.001
91  11 85  11‡ 0.001
7,943  1,896 7,456  1,600 0.001
85  17 86  15 0.001
130  20 135  18 0.002
70  9 74  9‡ 0.001
90  11 95  11‡ 0.001
11,116  2,920 11,628  2,599 0.269
0.77  0.25 0.71  0.20 0.001
1.95  0.64 1.99  0.64 0.629
2.67  0.87 2.96  1.02 0.001
128  39 130  39 0.131
50  17 53  21 0.229
0.05 vs. intermediate and upper tertiles; †p  0.04 vs.dial b
NT),of C
6)
1
)
)
9
3
4
10
5
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Coronary Hemodynamics During Adenosine February 15, 2005:553–8ange:24% to 129%) and, consequently, a modest increase
n the rate-pressure product. There were no significant
hanges in systolic, diastolic, or mean arterial blood pressure
uring adenosine infusion. These findings are consistent
ith prior reports in experimental (13) and human studies
3–5,14). The increase in HR with adenosine is likely the
esult of sympathetic activation caused by direct stimulation
f chemoreceptors in the carotid body (15) and, in some
atients, by an exaggerated peripheral vasodilator response
14).
In our study, patients with the lowest increase in HR with
denosine had slightly lower hyperemic blood flow (7% less)
nd higher CVR (8% greater) than those with greatest
ncrease in HR. However, these small changes in coronary
emodynamics and flow heterogeneity are unlikely to result
n significant differences in radiotracer uptake during MPI
nd, therefore, are unlikely to affect the sensitivity of
denosine myocardial perfusion scintigraphy for the detec-
ion of CAD. Indeed, Amanullah et al. (5) demonstrated
hat the sensitivity, specificity, and diagnostic accuracy of
denosine myocardial perfusion single-photon emission
omputed tomography for detecting CAD were not affected
y the presence or lack of significant changes in HR and
lood pressure in response to adenosine. Our results are not
nly consistent with these findings but, importantly, they
learly demonstrate a lack of relationship between hemody-
amic changes and coronary hyperemia.
The average peak adenosine-stimulated coronary blood
ow and CFR were slightly lower than those reported
reviously in healthy controls using the same methodology
16). This most likely reflects the fact that patients included
n the RAMPART trial were recruited on the basis of
ocumented dyslipidemia (i.e., low-density lipoprotein cho-
esterol levels 130 mg/dl) and/or a history of CAD. The
est and peak blood flows, as well as the coronary vasodilator
eserve values, in our study are comparable and entirely
onsistent with previous work in patients with risk factors or
ocumented CAD (17,18).
onclusions. We found that peripheral hemodynamic
hanges with adenosine are poor correlates of hyperemic
BF and CVR. Therefore, these changes cannot be used to
ssess the adequacy of a hyperemic response to adenosine.
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